Literature DB >> 8344751

Cytogenetic findings in 33 osteosarcomas.

F Mertens1, N Mandahl, C Orndal, B Baldetorp, H C Bauer, A Rydholm, T Wiebe, H Willén, M Akerman, S Heim.   

Abstract

Thirty-three osteosarcomas (OS) were analyzed cytogenetically. Clonal chromosome changes were detected in 17 cases. Six tumors had chromosome numbers in the diploid range, 6 in the triploid range, 1 in the tetraploid range and 1 in the pentaploid range, while 3 tumors had multiple clones with different ploidy levels. Including the present 17 tumors, a total of 27 OS with clonal aberrations have been reported. The recognizable structural rearrangements in these 27 tumors clustered to chromosome arms 1p, 1q, 3p, 3q, 7q, 11p, 17p and 22q. Chromosome bands 1q11, 1q21, 1q42 and 7q11 were the most frequently rearranged, and the most common numerical rearrangements were -3, -10, -13 and -15. Supernumerary ring chromosomes, in 2 tumors as the sole change, were found in all 3 parosteal OS, which is in agreement with the findings in 1 previously reported parosteal OS. The association between ring formation and parosteal morphology represents the first cytogenetic-morphologic entity among OS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344751     DOI: 10.1002/ijc.2910550109

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma.

Authors:  Shamini Selvarajah; Maisa Yoshimoto; Paul C Park; Georges Maire; Jana Paderova; Jane Bayani; Gloria Lim; Khaldoun Al-Romaih; Jeremy A Squire; Maria Zielenska
Journal:  Chromosoma       Date:  2006-08-09       Impact factor: 4.316

2.  Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping.

Authors:  N Entz-Werle; A Schneider; C Kalifa; A-C Voegeli; M-D Tabone; P Marec-Berard; L Marcellin; H Pacquement; P Terrier; P Boutard; N Meyer; M-P Gaub; P Lutz; A Babin; P Oudet
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

3.  Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations.

Authors:  S Xiao; A Renshaw; E S Cibas; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Establishment and cytogenetic characterization of a cell line from a pulmonary metastasis of osteosarcoma.

Authors:  Carolina Salinas-Souza; Indhira Dias Oliveira; Renato de Oliveira; Maria Teresa de Seixas Alves; Antonio Sergio Petrilli; Silvia Regina Caminada Toledo
Journal:  Cytotechnology       Date:  2012-07-26       Impact factor: 2.058

5.  Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma.

Authors:  Jennifer M Gillette; C Parker Gibbs; Sheila M Nielsen-Preiss
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-02-05       Impact factor: 2.416

6.  CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.

Authors:  G P Nielsen; K L Burns; A E Rosenberg; D N Louis
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

7.  Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63.

Authors:  Narasimharao V Marella; Michael J Zeitz; Kishore S Malyavantham; Artem Pliss; Sei-ichi Matsui; Sandra Goetze; Juergen Bode; Ivan Raska; Ronald Berezney
Journal:  Chromosome Res       Date:  2008-11-15       Impact factor: 5.239

8.  Estimating genomic instability mediated by Alu retroelements in breast cancer.

Authors:  Ana Cristina Fazza; Flavia Cal Sabino; Nathalia de Setta; Newton Antonio Bordin; Eloiza Helena Tajara da Silva; Claudia Marcia Aparecida Carareto
Journal:  Genet Mol Biol       Date:  2009-01-23       Impact factor: 1.771

9.  Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.

Authors:  Rosalvo Zósimo Bispo Júnior; Olavo Pires de Camargo
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Characteristic karyotypic features in lacrimal and salivary gland carcinomas.

Authors:  Y Jin; F Mertens; J Limon; N Mandahl; J Wennerberg; M Dictor; S Heim; F Mitelman
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.